Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia (RECONNECT-S)

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT01544608

NIS-NME-XXX-2011/1

Details and patient eligibility

About

The primary objective of this Non- Interventional Study (NIS) is to describe the use of atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to acute psychotic episode by evaluation of drug, dose and mode of administration of the medication.

Full description

RECONNECT-S BETA

Enrollment: 1,076 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Meet the diagnostic criteria for schizophrenia stated in The Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria.
• Subject is hospitalised due to an acute psychotic episode.
• Ability of the subject to understand and comply with the requirements of the study, as judged by the investigator.

Exclusion criteria

• Current participation in any clinical trial.
• Previous enrolment in the present NIS (in case of recurrence occurred during the enrolment period).

Trial design

1,076 participants in 1 patient group

Subjects who are hospitalized due to acute psychotic episode.

Description:

All subjects who are hospitalized due to acute psychotic episode. The subjects should be managed according to normal clinical practice until discharge time.